Frequencies of ETV6-RUNX1 fusion and hyperdiploidy in pediatric acute lymphoblastic leukemia are lower in Far East than West

Pediatric Blood and Cancer

Volumn 55, Issue 3, 2010, Pages 430-433

  Liang, Der Cherng ^a   Shih, Lee Yung ^b,c   Yang, Chao Ping ^d   Hung, Iou Jih ^d   Liu, Hsi Che ^a   Jaing, Tang Her ^d   Yeh, Ting Chi ^a   Liang, Sung Tzu ^a   Chang, Chia Ling ^a   Lee, En Hui ^a   Lai, Chung Liang ^c   Chang, Wan Hui ^e  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

^d CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

^e Childhood Cancer Foundation   (Taiwan)

Author keywords

Childhood acute lymphoblastic leukemia; ETV6 RUNX1 fusion; Far East; Hyperdiploidy (>50 chromosomes); The West

Indexed keywords

ETV6 RUNX1 FUSION PROTEIN; HYBRID PROTEIN; UNCLASSIFIED DRUG; ETV6 RUNX1 FUSION PROTEIN, HUMAN; ETV6-RUNX1 FUSION PROTEIN, HUMAN; ONCOPROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CHILD; CHILDHOOD LEUKEMIA; CHINA; CHINESE; CHROMOSOME ABERRATION; ETV6 RUNX1 GENE; FUSION GENE; GENE FREQUENCY; HONG KONG; HUMAN; HYPERDIPLOIDY; INFANT; JAPAN; KOREA; LYMPHOBLAST; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGAPORE; TAIWAN; UNITED STATES; WESTERN EUROPE; ASIAN; CAUCASIAN; COMPARATIVE STUDY; DIPLOIDY; DISEASE FREE SURVIVAL; EUROPE; FAR EAST; GENETICS; META ANALYSIS; MORTALITY; PRESCHOOL CHILD; SURVIVAL RATE;

ADOLESCENT; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CHILD, PRESCHOOL; DIPLOIDY; DISEASE-FREE SURVIVAL; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FAR EAST; HUMANS; INFANT; ONCOGENE PROTEINS, FUSION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SURVIVAL RATE; UNITED STATES;

EID: 77955481520     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22628     Document Type: Article

References (43)

1. Pui CH, Raimondi SC, Dodge RK, et al. Prognostic importance of structural chromosomal abnormalities in children with hyperdiploid (greater than 50 chromosomes) acute lymphoblastic leukemia. Blood 1989;73:1963-1967.
2. Shurtleff SA, Buijs A, Behm FG, et al. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia 1995;9:1985-1989. (Pubitemid 26023779)
3. McLean TW, Ringold S, Neuberg D, et al. TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia. Blood 1996;88:4252-4258.
4. Synold TW, Relling MV, Boyett JM, et al. Blast cell methotrexate- polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemia. J Clin Invest 1994;94:1996-2001.
5. Kaspers GJ, Smets LA, Pieters R, et al. Favorable prognosis of hyperdiploid common acute lymphoblastic leukemia may be explained by sensitivity to antimetabolites and other drugs: Results of an in vitro study. Blood 1995;85:751-756.
6. Kumagai M, Manabe A, Pui CH, et al. Stroma-supported culture in childhood B-lineage acute lymphoblastic leukemia cells predicts treatment outcome. J Clin Invest 1996;97:755-760.
7. Trueworthy R, Shuster J, Look T, et al. Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: A Pediatric Oncology Group Study. J Clin Oncol 1992;10:606-613.
8. Romana SP, Poirel H, Leconiat M, et al. High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood 1995;86:4263-4269.
9. Loh ML, Rubnitz JE. TEL/AML1-positive pediatric leukemia: Prognostic significance and therapeutic approaches. Curr Opin Hematol 2002;9:345-352.
10. Ramakers-van Woerden NL, Pieters R, Loonen AH, et al. TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia. Blood 2000;96:1094-1099.
11. Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet 2008;371:1030-1043.
12. Liang DC, Chou TB, Chen JS, et al. High incidence of TEL/AML1 fusion resulting from a cryptic t(12;21) in childhood B-lineage acute lymphoblastic leukemia in Taiwan. Leukemia 1996;10:991-993. (Pubitemid 26235932)
13. Liang DC, Shih LY, Yang CP, et al. Multiplex RT-PCR assay for the detection of major fusion transcripts in Taiwanese children with B-lineage acute lymphoblastic leukemia. Med Pediatr Oncol 2002;39:12-17.
14. Liang DC, Yang CP, Lin DT, et al. Long-term results of Taiwan Pediatric Oncology Group studies 1997 and 2002 for childhood acute lymphoblastic leukemia. Leukemia 2010;24:397-405.
15. Nakao M, Yokota S, Horiike S, et al. Detection and quantification of TEL/AML1 fusion transcripts by polymerase chain reaction in childhood acute lymphoblastic leukemia. Leukemia 1996;10:1463-1470.
16. Eguchi-Ishimae M, Eguchi M, Tanaka K, et al. Fluorescence in situ hybridization analysis of 12; 21 translocation in Japanese childhood acute lymphoblastic leukemia. Jpn J Cancer Res 1998;89:783-788.
17. Park KU, She CJ, Shin HY, et al. Low incidence of TEL/AML1 fusion and TEL deletion in Korean childhood acute leukemia by extra-signal fluorescence in situ hybridization. Cancer Genet Cytogenet 2001;126:73-77.
18. Woo HY, Kim DW, Park H, et al. Molecular cytogenetic analysis of gene rearrangements in childhood acute lymphoblastic leukemia. J Korean Med Sci 2005;20:36-41. (Pubitemid 40342202)
19. Gao YJ, Zhu XH, Yang Y, et al. Prevalence of ETV6-RUNX1 fusion in children with acute lymphoblastic in China. Cancer Genet Cytogenet 2007;178:567-560.
20. Tsang KS, Li CK, Chik KW, et al. TEL/AML1 rearrangement and the prognostic significance in childhood acute lymphoblastic leukemia in Hong Kong. Am J Hematol 2001;68:91-98.
21. Ariffin H, Chen SP, Kwok CS, et al. Ethnic differences in the frequency of subtypes of childhood acute lymphoblastic leukemia: Results of the Malaysia-Singapore Leukemia Study Group. J Pediatr Hematol Oncol 2007;29:27-31.
22. Pui CH, Campana D, Pei D, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med 2009;360:2730-2741.
23. Cayuela JM, Baruchel A, Orange C, et al. TEL-AML1 fusion RNA as a new target to detect minimal residual disease in pediatric B-cell precursor acute lymphoblastic leukemia. Blood 1996;88: 302-308.
24. Douet-Guilbert N, Morel F, Le Bris MJ, et al. A fluorescence in situ hybridization study of TEL-AML1 fusion gene in B-cell acute lymphoblastic leukemia (1984-2001). Cancer Genet Cytogenet 2003;144:143-147.
25. Escherich G, Horstmann MA, Zimmermann M, et al. Cooperative study group for childhood acute lymphoblastic leukaemia (COALL): Long-term results of trials 82, 85, 89, 92 and 97. Leukemia 2010;24:298-308.
26. Conter V, Arico M, Basso G, et al. Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia. Leukemia 2010;24:255-264.
27. Schmiegelow K, Forestier E, Hellebostad M, et al. Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia. Leukemia 2010;24:345-354.
28. Pui CH, Pei D, Sandlund JT, et al. Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia. Leukemia 2010;24:371-382.
29. Silverman LB, Stevenson KE, O'Brien JE, et al. Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000). Leukemia 2010;24:320-334.
30. Mor̈icke A, Zimmermann M, Reiter A, et al. Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia 2010;24:265-284.
31. Kamps WA, Bruin KM van der Pal-de Veerman AJP, et al. Long-term results of Dutch Childhood Oncology Group studies for children with acute lymphoblastic leukemia from 1984 to 2004. Leukemia 2010;24:309-319.
32. Salzer WL, Devidas M, Carroll WL, et al. Long-term results of the Pediatric Oncology Group Studies for childhood acute lymphoblastic leukemia 1984-2001: A report from the Children's Oncology Group. Leukemia 2010;24:355-370.
33. Kobayashi H, Maseki N, Homma C, et al. Clinical significance of chromosome abnormalities in childhood acute lymphoblastic leukemia in Japan. Leukemia 1994;8:1944-1950. (Pubitemid 24363073)
34. Tsuchida M, Ohara A, Manabe A, et al. Long-term results of Tokyo Children's Cancer Study Group trials for childhood acute lymphoblastic leukemia, 1984-1999. Leukemia 2010;24:383-396.
35. Aldrich MC, Zhang L, Wiemels JL, et al. Cytogenetics of Hispanic and White children with acute lymphoblastic leukemia in California. Cancer Epidemiol Biomarkers Prev 2006;15:578-581.
36. Moorman AV, Richards SM, Martineau M, et al. Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia. Blood 2003;102:2756-2762. (Pubitemid 37248844)
37. Forestier E, Heyman M, Andersen MK, et al. Outcome of ETV6/RUNX1-positive childhood acute lymphoblastic leukaemia in the NOPHO-ALL-1992 protocol: Frequent late relapses but good overall survival. Br J Haematol 2008;140:665-672.
38. Gaynon PS, Angiolillo AL, Carroll WL, et al. Long-term results of the Children's Cancer Group Studies for childhood acute lymphoblastic leukemia 1983-2002: A Children's Oncology Group Report. Leukemia 2010;24:285-297.
39. Bhatia S, Sather HN, Heerema NA, et al. Racial and ethnic differences in survival of children with acute lymphoblastic leukemia. Blood 2002;100:1957-1964. (Pubitemid 35001223)
40. Greaves MF, Wiemels J., Origins of chromosome translocations in childhood leukemia. Nat Rev Cancer 2003;3:639-649. (Pubitemid 37328819)
41. Pui CH, Relling MV, Downing JR. Acute lymphoblastic leukemia. N Eng J Med 2004;350:1535-1548.
42. Treviño LR, Yang W, French D, et al. Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat Genet 2009;41:1001-1005.
43. Papaemmanuil E, Hosking FJ, Vijayakrishnan J, et al. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet 2009;41:1006-1010.